• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Prasugrel Teva
    / Abic


    Active Ingredient
    Prasugrel 5, 10 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    28 ×5, 10 mg

    not in the basket chart

    Dosage

    One tablet a day. The tablet should not be chewed or crushed. Please refer to the license holder for further details.


    Indications

    Prasugrel Teva, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI] undergoing primary or delayed percutaneous coronary intervention (PCI).
    The increased efficacy should be balanced with the increased risk in patients with bleeding tendency in those who had TIA/CVA in the past and in those above the age of 75 or weight below 60 kg.


    Contra-Indications

    Hypersensitivity to the active substance or any of its excipients.
    Patients with active bleeding (such as bleeding from an ulcer in gastro intestinal system).
    Patients with history of a stroke or a transient ischemic attack (TIA).
    Patients with severe hepatic disease.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE